DEA Plans Special Registration for Telehealth Prescription of Controlled Substances - AAMC
DEA plans to create a special registration for telehealth prescribing of controlled substances, potentially replacing the COVID-19 flexibilities. This will affect providers and platforms relying on current waivers.
Aforeworn detected this change in the Telehealth Cross-State Licensing space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers should confirm how it applies to their specific situation before acting. There is a time constraint attached: No specific deadline yet; rulemaking expected in 2024. Act now to prepare.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
DEA announced plans for a special registration process for prescribing controlled substances via telehealth, which may end current flexibilities under the Ryan Haight Act and COVID-19 waivers.
Who it affects
Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers
What you must do
Monitor DEA rulemaking and prepare to apply for special registration; ensure compliance with state licensure and controlled substance laws.
Deadline
No specific deadline yet; rulemaking expected in 2024. Act now to prepare.
Never miss a change like this again
Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telehealth Cross-State Licensing
- DEA Proposes a Special Registry for Telehealth Providers of Controlled Substances - MedPage Today
- DEA Releases Long-Awaited Telehealth Special Registration Proposal, but Adoption Is Uncertain - McDermott+
- DEA Extends Telemedicine Flexibilities for Ketamine Prescribing: What Clinics Need to Know in 2026 - JD Supra
- Georgia medical board will limit virtual prescriptions - Atlanta Journal-Constitution
- DEA Proposed Telemedicine Prescribing Rule Could Burden Hospice Physicians and Hospice Operations - Morgan Lewis